Recent advances and future directions for the pharmacogenetic basis of anti-VEGF treatment response in neovascular age-related macular degeneration

Moeen Riaz; Paul N. Baird

doi:10.4103/1673-5374.205094

🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Home>Articles>Recent advances and future directions for the pharmacogenetic basis of anti-VEGF treatment response in neovascular age-related macular degeneration

DOI: 10.4103/1673-5374.205094

Recent advances and future directions for the pharmacogenetic basis of anti-VEGF treatment response in neovascular age-related macular degeneration

Moeen Riaz

Paul N. Baird

Machine-generated Keywords：

Publication Date：2017-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：2( 584-585 )

Neural Regeneration Research

ISTICSCI

ISSN：1673-5374

Year, Vol.(Issue)：2017,12(4)